Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,156.00
Bid: 12,124.00
Ask: 12,128.00
Change: -14.00 (-0.12%)
Spread: 4.00 (0.033%)
Open: 12,114.00
High: 12,258.00
Low: 12,114.00
Prev. Close: 12,170.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Europe dares to reopen as 200 millionth vaccine dose delivered

Mon, 10th May 2021 13:41

By Michael Gore and Estelle Shirbon

MADRID/LONDON, May 10 (Reuters) - As its vaccination drive
reaches a third of adults and COVID-19 infections ease, Europe
is starting to reopen cities and beaches, raising hopes that
this summer's holiday season can be saved before it is too late.

Exhilarated Spaniards chanting "freedom" danced in the
streets as a COVID-19 curfew ended in most of the country at the
weekend, while Greece reopened public beaches - with deckchairs
safely spaced.

With 200 million vaccine doses delivered, the European Union
is on track to achieve its goal of inoculating 70% of its adult
population by summer, Commission President Ursula von der Leyen
tweeted on Sunday.

And, in Germany, a first weekend of summer sun lifted
spirits after Health Minister Jens Spahn declared the third wave
of the pandemic finally broken.

Yet, Spahn warned: "The mood is better than the reality."

The national seven-day incidence of COVID-19 cases remains
high at 119 per 100,000 people, he said. "That makes it all the
more important to keep up the speed of the vaccination
campaign."

Across the EU, the seven-day incidence of COVID-19 is 185,
according to Our World in Data. That is far higher than in
countries such as Israel with 6, Britain (31), or the United
States (123), all of which made quicker early progress in their
vaccination drives.

HEAD START

In Britain, early orders and approval of vaccines and a
decision to give first doses to as many people as possible have
driven down infections and fatalities far more quickly.

Prime Minister Boris Johnson was expected to set out the
next phase of lockdown easing in England, giving the green light
to "cautious hugging" and allowing pubs to serve customers pints
inside after months of strict measures.

"The data reflects what we already knew - we are not going
to let this virus beat us," Johnson said ahead of an official
announcement later on Monday.

Vaccine deliveries were slower initially in the EU under its
centralised procurement strategy.

Now, with shots from BioNTech/Pfizer and Moderna relatively
plentiful, vaccinations as a share of the population in Europe
are growing while countries that made early advances see
slowdowns as they encounter hesitancy among the unvaccinated.

Some 31.6% of adults in 30 European countries have received
a first dose and 12% a full two-shot regime, the European Centre
for Disease Prevention and Control's COVID-19 Vaccine Tracker https://vaccinetracker.ecdc.europa.eu/public/extensions/COVID-19/vaccine-tracker.html#uptake-tab
showed.

France expects to give 20 million first injections by
mid-May, and hit 30 million by mid-June.

With infection rates falling and occupancy in hospital
intensive care units declining, France plans to start relaxing
its curfew and allow cafes, bars and restaurants to offer
outdoor service from May 19.

PICKING AND CHOOSING

Improving supply has given countries greater freedom to
adapt their strategies following reports of very rare, but
sometimes fatal, blood clotting in people who received shots
from AstraZeneca and Johnson & Johnson.

Germany has decided to make the two vaccines available to
anyone who wants them, as long as they have been advised by a
doctor - an offer aimed at younger adults who would have to wait
their turn otherwise.

Norway's vaccine commission made a similar call on Monday,
saying the AstraZeneca and J&J shots should be made available to
volunteers. Some Italian regions are also offering both shots to
people under 60.

With some governments shortening the gaps between doses, and
plans for an EU digital "green pass" scheme in June for
travellers to provide proof of vaccination or immunity, people
cooped up for months are finally daring to make holiday plans.

"We're pinning our hopes on tourism," said Nikos Venieris,
who manages a beach in Alimos, an Athens suburb.

Tourism accounts for about a fifth of Greece's economy and
jobs, and the country can ill afford another lost summer. Greece
is lifting restrictions on vaccinated foreigners from May 15.

(Writing by Douglas Busvine
Additional reporting by Jordi Rubio, Terje Solsvik, Gwladys
Fouche, Matthias Blamont, Emilio Parodi, John Miller, Alan
Charlish and Phoebe Fronista
Editing by Giles Elgood)

More News
3 Apr 2024 11:02

CORRECT: AstraZeneca, Daiichi make US progress with licence approvals

(Correcting the description of extravascular haemolysis' effects on patients with paroxysmal nocturnal haemoglobinuria)

Read more
2 Apr 2024 15:22

London close: Stocks turn red on return from Easter break

(Sharecast News) - UK stocks experienced a downturn by the end of trading on Tuesday, as investors resumed activity following the extended weekend, with initial gains reversed by the close ahead of a week marked by a number of key economic data releases.

Read more
2 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 buoyed by UK manufacturing growth

(Alliance News) - The FTSE 100 in London was up at midday on Tuesday, reacting to the UK manufacturing sector returning growth and further PMI data across the globe.

Read more
2 Apr 2024 10:25

AstraZeneca and Daiichi make US progress with latest licence approvals

(Alliance News) - AstraZeneca PLC on Tuesday noted significant progress for two of its clinical-stage treatments in the US.

Read more
2 Apr 2024 09:54

LONDON BROKER RATINGS: Bernstein starts AstraZeneca at 'outperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
2 Apr 2024 09:09

LONDON MARKET OPEN: FTSE 100 up as oil majors and gold miners shine

(Alliance News) - Stock prices in London opened higher on Tuesday, in confident trade following the long Easter weekend, ahead of a UK manufacturing sector reading later in the morning.

Read more
2 Apr 2024 08:05

LONDON BRIEFING: HSBC in special payout on Canada sale; Astra FDA win

(Alliance News) - London's FTSE 100 traded higher on Tuesday following the long weekend, as investors react to US data, and look ahead to manufacturing sector readings from Europe later.

Read more
2 Apr 2024 07:08

US FDA gives green light for use of AstraZeneca's Voydeva

(Sharecast News) - America's drug regulator gave the green light to AstraZeneca's for the add-on use of Voydeya in the treatment of extravascular haemolysis (EVH) in patients with paroxysmal nocturnal haemoglobinuria (PNH).

Read more
27 Mar 2024 12:02

LONDON MARKET MIDDAY: FTSE 100 underperforms ahead of US PCE data

(Alliance News) - Stock prices in London were lower at midday on Wednesday, but trade was more confident in mainland Europe, with focus turning to the release of the US Federal Reserve's preferred inflation gauge on Friday.

Read more
27 Mar 2024 11:56

C4X Discovery seeks AIM delisting but half-year revenue skyrockets

(Alliance News) - C4X Discovery Holdings PLC shares plunged on Wednesday after it said it plans to delist from AIM in London, due to "the recent downturn in the financial markets" hampering its valuation.

Read more
27 Mar 2024 09:19

AstraZeneca treatments become "first and only" to be approved in Japan

(Alliance News) - AstraZeneca PLC announced on Wednesday the approval of two of its treatments for use in Japan.

Read more
27 Mar 2024 09:03

LONDON MARKET OPEN: FTSE 100 slips as unease lingers before US data

(Alliance News) - Stock prices in London edged lower after the open on Wednesday, with some nervy trade ahead of a US inflation reading later in the week.

Read more
27 Mar 2024 08:02

LONDON BRIEFING: Diploma makes buy; Astra wins Japan drug approvals

(Alliance News) - Stocks in London opened in a muted fashion on Wednesday, with some unease lingering in equity markets ahead of a US inflation reading later in the week.

Read more
26 Mar 2024 10:18

China to speed up 'new productive forces', vice president says

BEIJING, March 26 (Reuters) - China will accelerate the development of "new productive forces" and bolster stability and security for the global economy, Vice President Han Zheng told an investment forum in Beijing, as the world's no.2 economy seeks to reassure anxious foreign firms.

Read more
25 Mar 2024 12:09

LONDON MARKET MIDDAY: Stocks make tepid start to new week

(Alliance News) - Stock prices in London were down at midday on Monday, giving back some gains from last week, when equities were boosted by central bank decisions and accompanying statements which investors saw as dovish.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.